Correlation of Uric Acid Levels and Parameters of Metabolic Syndrome

被引:60
作者
Cibickova, L. [1 ]
Langova, K. [2 ]
Vaverkova, H. [1 ]
Kubickova, V. [3 ]
Karasek, D. [1 ]
机构
[1] Palacky Univ, Fac Med & Dent, Dept Internal Med Nephrol Rheumatol & Endocrinol, Olomouc, Czech Republic
[2] Palacky Univ, Fac Med & Dent, Dept Med Biophys, Olomouc, Czech Republic
[3] Univ Hosp, Dept Clin Biochem, Olomouc, Czech Republic
关键词
Metabolic syndrome; Uric acid; Hypertriglyceridemic waist; Lipid metabolism; Insulin resistance; INSULIN-RESISTANCE; RISK; PLASMA; HYPERURICEMIA; DEFINITION; GLUCOSE;
D O I
10.33549/physiolres.933410
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
Hyperuricemia has been described as associated with the risk of development metabolic syndrome; however the relationship between the uric acid level and particular parameters of metabolic syndrome remained unclear. We performed a cross-sectional study on a cohort of 833 dyslipidemic patients and correlated their levels of uric acid with parameters of insulin resistance, lipid metabolism, C-reactive protein, anthropometric parameters. We also defined patients with hypertriglyceridemic waist phenotype and compered their uric acid levels with those without this phenotype. We found that levels of uric acid are associated with parameters of metabolic syndrome. Specifically, dyslipidemia characteristic for metabolic syndrome (low HDL cholesterol and high triglycerides) correlates better with uric acid levels than parameters of insulin resistance. Also waist circumference correlates better with uric acid levels than body mass index. Patients with hypertriglyceridemic waist phenotype had higher levels of uric acid when compared with patients without this phenotype. Serum uric acid levels are even in low levels linearly correlated with parameters of metabolic syndrome (better with typical lipid characteristics than with parameters of insulin resistance) and could be associated with higher cardiovascular risk.
引用
收藏
页码:481 / 487
页数:7
相关论文
共 25 条
[1]
Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[2]
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]
2-S
[4]
The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk Prospective Population Study [J].
Arsenault, Benoit J. ;
Lemieux, Isabelle ;
Despres, Jean-Pierre ;
Wareham, Nicholas J. ;
Kastelein, John J. P. ;
Khaw, Kay-Tee ;
Boekholdt, S. Matthijs .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (13) :1427-1432
[5]
Serum Uric Acid Levels and the Risk of Type 2 Diabetes: A Prospective Study [J].
Bhole, Vidula ;
Choi, Jee Woong J. ;
Kim, Sung Woo ;
de Vera, Mary ;
Choi, Hyon .
AMERICAN JOURNAL OF MEDICINE, 2010, 123 (10) :957-961
[6]
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome [J].
Carbone, Federico ;
Montecucco, Fabrizio ;
Mach, Francois ;
Pontremoli, Roberto ;
Viazzi, Francesca .
THROMBOSIS AND HAEMOSTASIS, 2013, 110 (05) :940-958
[7]
Associations between low levels of serum uric acid and cardiometabolic parameters [J].
Ciarla, Sara ;
Giorgini, Paolo ;
Struglia, Manuela ;
Striuli, Rinaldo ;
Necozione, Stefano ;
Desideri, Giovambattista ;
Properzi, Giuliana ;
Ferri, Claudio .
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2015, 121 (04) :139-143
[8]
Correlation of Lipid Parameters and Markers of Insulin Resistance: Does Smoking Make a Difference? [J].
Cibickova, L. ;
Karasek, D. ;
Langova, K. ;
Vaverkova, H. ;
Orsag, J. ;
Lukes, J. ;
Novotny, D. .
PHYSIOLOGICAL RESEARCH, 2014, 63 :S387-S393
[9]
Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9 [J].
DeBosch, Brian J. ;
Kluth, Oliver ;
Fujiwara, Hideji ;
Schuermann, Annette ;
Moley, Kelle .
NATURE COMMUNICATIONS, 2014, 5
[10]
Atherogenic index of plasma [Log(Triglycerides/HDL-cholesterol:: Theoretical and practical implications [J].
Dobiásová, M .
CLINICAL CHEMISTRY, 2004, 50 (07) :1113-1115